Norvasc Drug Card

  • December 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Norvasc Drug Card as PDF for free.

More details

  • Words: 437
  • Pages: 1
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name amlodipine

Trade Name Norvasc

Peak 6-9 hrs

Onset Unknown

Classification Dose Route Time/frequency Antihypertensive, 2.5 mg PO Q Day calcium channel blocker Duration Normal dosage range 24 hrs Initiate therapy at 2.5 mg/day, increase as required/tolerated (up to 10 mg/day).

Why is your patient getting this medication Hypertension

For IV meds, compatibility with IV drips and/or solutions N/A

Mechanism of action and indications (Why med ordered) Inhibits the transport of calcium into myocardial and vascular smooth muscle cells, resulting in inhibition of excitationcontraction coupling and subsequent contraction. Systemic vasodilation resulting in decreased blood pressure. Coronary vasodilation resulting in decreased frequency and severity of attacks of angina.

Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity, blood pressure < 90 mm Hg. Use cautiously in: Severe hepatic impairment (dosage reduction recommended), geriatric patients (dosage reduction recommended; increased risk of hypotension), aortic stenosis, history of CHF. Common side effects Headache, peripheral edema.

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Additive hypotension may occur when used concurrently with other antihypertensives (Prinivil, Coreg) or acute ingestion of alcohol.

Nursing Process- Assessment (Pre-administration assessment) Monitor blood pressure and pulse before therapy, during dose titration, and periodically during therapy. Monitor ECG periodically during prolonged therapy. Monitor intake and output ratios and daily weight. Assess for signs of CHF (peripheral edema, rales/crackles, dyspnea, weight gain, jugular venous distention).

Lab value alterations caused by medicine Total serum calcium concentrations are not affected by calcium channel blockers. Be sure to teach the patient the following about this medication Do not double doses. May need to be discontinued gradually. Instruct patient on correct technique for monitoring pulse. Instruct patient to contact health care professional if heart rate is <50 bpm. Caution patient to change positions slowly to minimize orthostatic hypotension. May cause drowsiness or dizziness. Advise patient to avoid driving or other activities requiring alertness until response to the medication is known. Instruct patient on importance of maintaining good dental hygiene and seeing dentist frequently for teeth cleaning to prevent tenderness, bleeding, and gingival hyperplasia (gum enlargement). Advise patient to notify health care professional if irregular heartbeats, dyspnea, swelling of hands and feet, pronounced dizziness, nausea, constipation, or hypotension occurs or if headache is severe or persistent. Advise patient to take blood pressure weekly and to report significant changes to health care professional. Assessment Evaluation Why would you hold or not give this med? Check after giving Blood pressure < 90 mm Hg or heart rate < 50 Decrease in blood pressure. bpm.

Related Documents

Norvasc Drug Card
December 2019 15
Drug Norvasc
May 2020 5
Norvasc
May 2020 7
Norvasc
November 2019 24
Drug Card
November 2019 32